Intellia Therapeutics Stock Forecast

Sell candidate since Jul 10, 2026 Loss -23.39%

The Intellia Therapeutics Inc stock price gained 2.06% on the last trading day (Tuesday, 28th Jul 2026), rising from $10.67 to $10.89. During the last trading day the stock fluctuated 7.68% from a day low at $10.15 to a day high of $10.93. The price has fallen in 8 of the last 10 days and is down by -18.12% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 5 million shares were bought and sold for approximately $52.83 million.

The stock is at the lower part of a very wide and horizontal trend in the short term, and normally this may pose a good buying opportunity, though a breakdown through the bottom trend line at $10.67 will give a strong sell signal and a trend shift may be expected. Given the current horizontal trend, you can expect Intellia Therapeutics Inc stock with a 90% probability to be traded between $10.62 and $17.73 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

NTLA Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, July 27, 2026, and so far it has risen 2.06%. Further rise is indicated until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Intellia Therapeutics Inc stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $10.99 and $14.06. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Intellia Therapeutics Inc stock

Intellia Therapeutics Inc finds support from accumulated volume at $10.73 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.780 between high and low, or 7.68%. For the last week, the stock has had daily average volatility of 5.42%.

Intellia Therapeutics Inc is oversold on RSI14 (13). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NTLA) For The Upcoming Trading Day Of Wednesday 29th

For the upcoming trading day on Wednesday, 29th we expect Intellia Therapeutics Inc to open at $10.66, and during the day (based on 14 day Average True Range), to move between $10.43 and $11.35, which gives a possible trading interval of +/-$0.93 (+/-8.92%) up or down from last closing price. If Intellia Therapeutics Inc takes out the full calculated possible swing range there will be an estimated 8.92% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $10.73 (1.47%) than the resistance at $12.45 (14.28%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Intellia Therapeutics Inc stock A Buy?

Intellia Therapeutics Inc holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.064 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 29, 2026 - $10.66 ( 2.14%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk